REQUEST A DEMO
Total
USD $0.00
Search more companies

Clinilab CIA Ltda (Ecuador)

Main Activities: Medical and Diagnostic Laboratories
Full name: Clinilab CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Clinilab CIA Ltda is based in Ecuador. The head office is in Cuenca. It operates in the Medical and Diagnostic Laboratories industry. It was incorporated on February 28, 2012. Clinilab CIA Ltda currently employs 6 (2020) people. In 2023, the company reported a net sales revenue increase of 32.74%. There was a total growth of 21.09% in Clinilab CIA Ltda’s total assets over the same period.

Headquarters
Alfonso Moreno Mora 1-75
Cuenca; Azuay;

Contact Details: Purchase the Clinilab CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Clinilab CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Clinilab CIA Ltda report to view the information.
Registered Capital:
Purchase the Clinilab CIA Ltda report to view the information.
Incorporation Date:
February 28, 2012
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Clinilab CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
32.74%
Total operating revenue
32.74%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
21.09%
Total equity
25.05%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?